NEUROPACE INC
NeuroPace (NPCE) is a small-cap medical device company that develops the RNS® System, an implantable, closed‑loop neurostimulation device for adults with drug‑resistant focal epilepsy. The system monitors brain activity and delivers brief electrical stimulation to disrupt seizures, aiming to reduce seizure frequency over time. Key drivers for the company include increased adoption at specialised epilepsy centres, device replacement and software upgrades, further clinical data, and potential label expansion or reimbursement improvements. Investors should note NeuroPace’s modest market capitalisation (≈$357M) and the typical medtech risks: reliance on clinical outcomes, regulatory and reimbursement processes, competition from other neurostimulation platforms, and the need to scale surgical adoption. Financials for smaller medtechs can be volatile, and returns are not guaranteed. This is educational information only and not personal investment advice; suitability depends on an investor’s objectives, timeframe and risk tolerance.
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying NeuroPace's stock, with a target price indicating potential growth ahead.
Financial Health
NeuroPace is performing well with strong revenue and cash flow, showcasing solid profitability.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring NPCE
Wearable Health Stocks: Growth Potential vs Competition
Apple's recent FDA clearance for its Apple Watch hypertension feature marks a major step in wearable medical technology. This development opens up investment opportunities in the broader ecosystem of connected health devices and remote patient monitoring services.
Published: September 12, 2025
Explore BasketBrain-Computer Interface
This collection features pioneering companies creating revolutionary pathways between the human brain and machines. These carefully selected stocks represent the cutting edge of neural technology, with potential to transform healthcare and computing through innovative brain signal interpretation.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Responsive Neurostimulation
The RNS System’s closed‑loop approach targets seizures as they start, a clinical differentiation worth watching — though outcomes and adoption can vary.
Adoption & Reimbursement
Broader use depends on referrals, training and payer coverage; improvements could support revenue, but reimbursement remains a key uncertainty.
Clinical Evidence Path
Long‑term data and potential label expansions influence the market opportunity, yet regulatory hurdles and competition may affect timelines.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
